Biological role of EET in induction of vascular endotberial growth factor underr hypoxia
Biological role of EET in induction of vascular endotberial growth factor underr hypoxia
批准号:
16590129
负责人:
IMAOKA Susumu
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cytochrome P450 (P450) catalyze the NADPH-dependent oxidation of arachidonic acid to several unique eicosanoids such as epoxyeicosatrienoic acid (EET) which has four isomers, 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET. A particular interest in the epoxygenase reaction has developed because of the potent biological activities (modulation of vascular tone and anti-inflammatory activity etc.) attributed to the EETs. I focused on a new biological function of EETs which induce vascular endotherial growth factor (VEGF) under hypoxia. In this study, human hepatoma cell, Hep3B and human umbilical artery endotherial cell (HUAEC) were used under normoxic and hypoxic conditions. An inhibitor for phospholipase A2 which supplies arachidonic acid from plasma membrane, MAFP, inhibited the VEGF induction in HUAEC under hypoxia. NADPH-P450 reductase (NPR) supplies electrons to P450 and is necessary for P450 to oxidize arachidonic acid. An inhibitor for NPR, DPIC, inhibited the VEGF induction. These results suggest that arachidonic acid and P450 are important for the VEGF induction in HUAEC under hypoxia. The same effects on Hep3B cells were also observed. In Hep3B cells, inhibitors for P450s, sulfaphenazol (an inhibitor for CYP2C8 and CYP2C9) and ketoconazole (an inhibitor for CYP3A) inhibited hypoxia response (erythropoietin induction) efficiently. Addition of 11,12-EET or 14,15-EET induced VEGF in HUAEC under hypoxia but hydration products, 11,12-DHETE and 14,15-DHETE did not induce VEGF. Hypoxia-inducible factor (HIF-1) is necessary for induction of VEGF under hypoxia. 11,12-EET and 14,15-EET did not change the levels of HIF-1. In conclusion, EETs produced by P450s play an important role in hypoxic response of cells. EETs induced VEGF independent on HIF-1 which is an important factor of hypoxic response.
期刊论文(60)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Purification of NADPH-P450 reductase (NPR) from Xenopus laevis and developmental change in NPR expression.
从非洲爪蟾中纯化 NADPH-P450 还原酶 (NPR) 以及 NPR 表达的发育变化。
DOI:
--
发表时间:
2006
期刊:
Life Sciences vol.79
影响因子:
--
作者:
[Katada, T., Kinoshita T., T.Mori]
通讯作者:
T.Mori
DOI:
10.1248/bpb.28.2240
发表时间:
2005-12-01
期刊:
BIOLOGICAL & PHARMACEUTICAL BULLETIN
影响因子:
2
作者:
[Imaoka, S, Obata, N, Funae, Y]
通讯作者:
Funae, Y
Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brein.
细胞色素 P450 2D 催化脑中类固醇 21-羟基化。
DOI:
--
发表时间:
2004
期刊:
Endocrinology 145(2)
影响因子:
--
作者:
[Kishimoto, W. et al.]
通讯作者:
W. et al.
Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1α protein.
芹菜素通过降解 HIF-1α 蛋白抑制内皮细胞中 VEGF 的表达,VEGF 是血管生成的重要因子。
DOI:
--
发表时间:
2004
期刊:
FEBS Lett. 575
影响因子:
--
作者:
[Osada, M., Imaoka, S., Funae, Y.]
通讯作者:
Y.
Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism of rat P450 with that human P450 orthologs.
大鼠细胞色素 P450 在各种组织中的定位以及大鼠 P450 与人 P450 直向同源物的花生四烯酸代谢的比较。
DOI:
--
发表时间:
2005
期刊:
Drug Metab. and Phamacokinet. 20(6)
影响因子:
--
作者:
[Imaoka, S. et al.]
通讯作者:
S. et al.
共 14 条
Protein interference in mammalian cells and analysis of biological functions of PDI and sEH
-
批准号:23655162
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2011
-
负责人:IMAOKA Susumu
-
依托单位:
Biological functions of polyphenols-Search for their bindingfactors and mechanism in the binding
-
批准号:21310045
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2009
-
负责人:IMAOKA Susumu
-
依托单位:
Research oftargetproteinfor endocrine-disruptingchemicals such as bisphenol A during development of the central nervous system
-
批准号:19310041
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.91万
-
财政年份:2007
-
负责人:IMAOKA Susumu
-
依托单位:
New function of NADPH-P450 reductase(NPR) : Regulation of hypoxia-response genes by NPR.
-
批准号:14572095
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2002
-
负责人:IMAOKA Susumu
-
依托单位:
Mechanism of Renal Injury by Active Oxygen Species Produced by Cytochrome P450
-
批准号:08670185
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:IMAOKA Susumu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
-
批准号:JCZRLH202601503
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
-
批准号:2026JJ80680
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:姜平
-
依托单位:
Decorin调控ADAMTS12 m6A甲基化与IL12B/VEGF免疫互作介导肥胖合并妊娠期糖尿病子代心血管疾病的作用研究
-
批准号:2026JJ81694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗慧
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
金黄跌打散联合海桐皮汤通过HIF-1α/VEGF通路干预新生血管形成防治软骨损伤的机制研究
-
批准号:2026JJ81074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟炜钰
-
依托单位:
基于蛋白质组学探究VEGF转染的人脐带间充质干细胞改善小鼠急性肝衰竭的机制及验证研究
-
批准号:2026JJ81849
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈海鸥
-
依托单位:
化痰通络汤调控PIEZO1/ACSL4/VEGF轴阻断线粒体机械转导增强内皮细胞铁死亡抗性促缺血性中风后血管新生的机制研究
-
批准号:2026JJ81884
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱新华
-
依托单位:
IGF2BP2通过m6A甲基化修饰调控VEGF-C转录促进头颈鳞癌淋巴管生成的机制研究
-
批准号:JCZRQNB202600634
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
研究川崎病患者血清中VEGF水平与冠状动脉异常的相关性
-
批准号:2026JJ82691
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:鲁涛
-
依托单位:
养精通络方调控HIF-1α/VEGF信号通路调控“氧化应激-线粒体自噬”促进薄型子宫内膜修复的机制研究
-
批准号:2026JJ82186
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曾晶
-
依托单位: